U.S. Physical Therapy (NYSE:USPH) Releases Quarterly Earnings Results, Misses Estimates By $0.07 EPS

U.S. Physical Therapy (NYSE:USPH) announced its earnings results on Tuesday. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.07), Briefing.com reports. The business had revenue of $155.70 million during the quarter, compared to analyst estimates of $153.30 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The firm’s revenue was up 4.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.59 earnings per share.

U.S. Physical Therapy Trading Down 2.5 %

NYSE:USPH traded down $2.68 during trading hours on Wednesday, hitting $102.91. 35,113 shares of the stock were exchanged, compared to its average volume of 68,376. The company’s 50 day moving average is $105.26 and its two-hundred day moving average is $96.31. U.S. Physical Therapy has a twelve month low of $78.08 and a twelve month high of $124.11. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $1.55 billion, a P/E ratio of 76.52, a price-to-earnings-growth ratio of 4.99 and a beta of 1.39.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were issued a dividend of $0.44 per share. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. The ex-dividend date was Monday, March 11th. This represents a $1.76 annualized dividend and a yield of 1.71%. U.S. Physical Therapy’s dividend payout ratio is currently 130.37%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, insider Eric Joseph Williams sold 1,500 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $104.96, for a total transaction of $157,440.00. Following the completion of the sale, the insider now owns 19,314 shares in the company, valued at approximately $2,027,197.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Edward L. Kuntz sold 2,500 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $104.26, for a total value of $260,650.00. Following the completion of the sale, the director now owns 5,780 shares in the company, valued at approximately $602,622.80. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Eric Joseph Williams sold 1,500 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $104.96, for a total transaction of $157,440.00. Following the completion of the sale, the insider now owns 19,314 shares of the company’s stock, valued at approximately $2,027,197.44. The disclosure for this sale can be found here. In the last quarter, insiders have sold 10,829 shares of company stock valued at $1,141,535. 1.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

USPH has been the topic of several recent analyst reports. Barrington Research boosted their target price on U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. JPMorgan Chase & Co. boosted their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a report on Wednesday, March 13th. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Monday, March 18th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $125.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.